Mertz, Philippe
Costedoat-Chalumeau, Nathalie
Ferrada, Marcela A.
Moulis, Guillaume
Mekinian, Arsène
Grayson, Peter C.
Arnaud, Laurent https://orcid.org/0000-0002-8077-8394
Article History
Accepted: 27 March 2024
First Online: 2 May 2024
Competing interests
: G.M. has received research grants from Amgen, Grifols, Novartis and Sanofi, and is on the advisory board for Amgen, Argenx, Grifols, Novartis, Sanofi and Sobi. The other authors declare no competing interests.